83P Evaluation of concordance between PD-L1 immunohistochemistry 28-8 and 22C3 pharmDx assays in metastatic urothelial carcinoma (mUC) in PIVOT-10.

Authors :: Siefker-Radtke, A.O.
Hoch, U.
Loriot, Y.
Balar, A.V.
Bilen, M.A.
Tannir, N.M.
Cho, D.C.
Choudhury, A.
Chien, D.
Yu, D.
Currie, S.L.
Novotny, J.
Santiago, L.
Tagliaferri, M.A.
Zalevsky, J.
Huddart, R.A.
Source :: Annals of Oncology. 2021 Supplement 5, Vol. 32, pS392-S393. 2p.
Publication Year :: 2021

Subjects :: *TRANSITIONAL cell carcinoma
*PROGRAMMED death-ligand 1
*IMMUNOHISTOCHEMISTRY
*METASTASIS

Full Text Access

Tools